Furosemide
- Product NDC
- 0615-0446
- 11-digit product format
- 006150446
- Labeler code
- 0615
- Product ID
- 0615-0446_7c5111c8-7a8c-4e90-b257-4379b7d469de
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- NDA018413
- Marketing category
- NDA
- Marketing start
- 1983-11-30
- Marketing end
- 0000-00-00
- Substance
- FUROSEMIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-0446-05 | 2021-05-18 | C162847 | 48780-1 | 9d75b9d0-0e53-f424-e053-dadaa90a57ce | 5de52c23-89e5-4a93-8814-7571dd47633c |
| 0615-0446-14 | 2021-05-18 | C162847 | 48780-1 | 9d75b9d0-0e53-f424-e053-dadaa90a57ce | 5de52c23-89e5-4a93-8814-7571dd47633c |
| 0615-0446-31 | 2021-05-18 | C162847 | 48780-1 | 9d75b9d0-0e53-f424-e053-dadaa90a57ce | 5de52c23-89e5-4a93-8814-7571dd47633c |
| 0615-0446-39 | 2021-05-18 | C162847 | 48780-1 | 9d75b9d0-0e53-f424-e053-dadaa90a57ce | 5de52c23-89e5-4a93-8814-7571dd47633c |
| 0615-0446-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0e53-f424-e053-dadaa90a57ce | 5de52c23-89e5-4a93-8814-7571dd47633c |
| 0615-0446-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0e53-f424-e053-dadaa90a57ce | 5de52c23-89e5-4a93-8814-7571dd47633c |
| 0615-0446-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0e53-f424-e053-dadaa90a57ce | 5de52c23-89e5-4a93-8814-7571dd47633c |
| 0615-0446-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0e53-f424-e053-dadaa90a57ce | 5de52c23-89e5-4a93-8814-7571dd47633c |